Sunil Healthcare

Sunil Healthcare Financial Leverage

The Financial Leverage (Equity Multiplier) of Sunil Healthcare (537253.BO) as of Oct 16, 2026 is 2.41. In the previous year, Financial Leverage (Equity Multiplier) was 2.32 — a change of 3.92% (higher).

Financial Leverage

2.41

YoY

3.92%

Last updated:

Financial Leverage (Equity Multiplier) of Sunil Healthcare is 2025 2.41 . Financial Leverage (Equity Multiplier) of Sunil Healthcare was 2024 2.32 . It decreases by 3.92% higher compared to the previous year.

The Sunil Healthcare Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2018
3.00 INR
Jan 1, 2019
2.94 INR
Jan 1, 2020
2.92 INR
Jan 1, 2021
2.76 INR
Jan 1, 2022
2.20 INR
Jan 1, 2023
2.16 INR
Jan 1, 2024
2.32 INR
Jan 1, 2025
2.41 INR
The Sunil Healthcare Financial Leverage history
YEARFinancial LeverageYoY
2.41+3.92%
2.32+7.71%
2.16-1.76%
2.20-20.38%
2.76-5.55%
2.92-0.84%
2.94-1.77%
3.00-1.39%
3.04+10.08%
2.76+12.46%
2.46+2.04%
2.41—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Sunil Healthcare Stock analysis

What does Sunil Healthcare do? Sunil Healthcare Ltd is a company based in New Delhi, India, engaged in the manufacture of empty hard gelatin capsule shells. The company went public through an IPO on January 23, 2014. It produces empty hard gelatin capsule shells, HPMC capsule shells, and ayurvedic medicines. The firm's products are categorized by type, specifications, and customization options. Among its capsule offerings are BSE/TSE Free Capsules, Pearl Capsules, Liquid Fill Capsules, Stick Free Capsules, Flavored Capsules, SLS Free Capsules, Natural Color Capsules, Non-Azo Capsules, and Preservative Free Capsules. Hard gelatin capsule shells are available in nine sizes, including 00, 0SEL, 0EL, 0, 1, 2, 3, 4, and 5. Ayurvedic products include haldi extract, ginger extract, vasaka extract, and salaki extract. HPMC capsules are marketed as a vegetarian alternative to gelatin due to their plant-based origin and similar physical appearance. The company operates a manufacturing plant in Alwar, Rajasthan, India. Sunil Healthcare Ltd maintains a website at www.sunilhealthcare.com for further information. Sunil Healthcare is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sunil Healthcare stock

Financial Leverage (Equity Multiplier) of Sunil Healthcare is 2.41 in 2025.

Financial Leverage (Equity Multiplier) of Sunil Healthcare changed from 2.32 to 2.41, representing a 3.92% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Sunil Healthcare since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Sunil Healthcare with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — Sunil Healthcare

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Sunil Healthcare